Charles S. Fermaintt

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site”.

Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2021847118

N/A

0DataRank · unranked

92 citations

Qi-Yin Chen, Ranjala Ratnayake, Charles S. Fermaintt, Daniel Lucena‐Agell, Francesca Bonato +9 more

Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA

Molecular Pharmacology(2021)10.1124/molpharm.121.000297

N/A

0DataRank · unranked

31 citations

Leila Takahashi‐Ruiz, Huiyun Liang, Susan L. Mooberry, April L. Risinger, Charles S. Fermaintt

Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential

Cancers(2021)10.3390/cancers13112834

N/A

0DataRank · unranked

18 citations

Thilini Peramuna, Shengxin Cai, Leila Takahashi‐Ruiz, Jacob Nathaniel Essif, Corena V. Grant +5 more

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models

Cancers(2022)10.3390/cancers14235962

N/A

0DataRank · unranked

31 citations

Charles S. Fermaintt, Nancy Wilkinson, Peter Y. W. Chan, Susan L. Mooberry, April L. Risinger +1 more